TCR2 Therapeutics Q1 EPS $(1.03) Down From $(0.76) YoY
Author: Benzinga Newsdesk | May 11, 2023 06:46am
TCR2 Therapeutics (NASDAQ:TCRR) reported quarterly losses of $(1.03) per share. This is a 35.53 percent decrease over losses of $(0.76) per share from the same period last year.